DRMA vs ENSC
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
DRMA
49.2
AI Score
VS
ENSC Wins
ENSC
67.9
AI Score
Investment Advisor Scores
ENSC
68score
Recommendation
BUY
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | DRMA | ENSC | Winner |
|---|---|---|---|
| Revenue | 74,137 | 2.13M | ENSC |
| Net Income | -7.64M | -6.13M | ENSC |
| Net Margin | -10300.1% | -288.3% | ENSC |
| Operating Income | -7.80M | -6.14M | ENSC |
| ROE | -195.5% | 783.8% | ENSC |
| ROA | -115.1% | -207.2% | DRMA |
| Total Assets | 6.64M | 2.96M | DRMA |
| Cash | 4.82M | 676,704 | DRMA |
Relative Price Performance (Last 90 Days)
DRMA 1M: -18.6%
· 3M: -55.4%
ENSC 1M: -36.2%
· 3M: +4.7%
Current Technical Phase
DRMA
MarkdownSell / avoid
Price below a falling SMA50 (slope -18.7%), weak momentum, RSI 38
ENSC
NeutralHold
Mixed signals - no dominant trend phase, RSI 38
Fundamentals Snapshot
| Metric | DRMA | ENSC |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -0.5 | -7.2 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | -0.2% |
| Gross Margin | — | -1.8% |
| Operating Margin | 0.0% | -2.2% |
| EPS | -4.39 | -2.47 |
| Dividend Yield | — | — |
Frequently Asked Questions
Based on our detailed analysis, ENSC is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.